| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042685410 |
| P356 | DOI | 10.1245/S10434-013-3207-Z |
| P698 | PubMed publication ID | 24046103 |
| P50 | author | Murray Brennan | Q18977783 |
| Ronald P DeMatteo | Q89998373 | ||
| Jennifer Lafemina | Q125264362 | ||
| T Peter Kingham | Q37839817 | ||
| Yuman Fong | Q88653122 | ||
| P2093 | author name string | Mithat Gonen | |
| Peter J Allen | |||
| Michael I D'Angelica | |||
| William R Jarnagin | |||
| Camilo Correa-Gallego | |||
| Richard Do | |||
| P2860 | cites work | Intraductal papillary mucinous neoplasms of the pancreas: an updated experience | Q24540094 |
| Prevalence of unsuspected pancreatic cysts on MDCT | Q24650018 | ||
| Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas | Q28362865 | ||
| Cystic pancreatic neoplasms: observe or operate | Q33201551 | ||
| Cystic lesions in the pancreas: when to watch, when to resect | Q34028043 | ||
| Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas | Q34560967 | ||
| Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. | Q35742485 | ||
| The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm | Q35920101 | ||
| Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. | Q36016143 | ||
| International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas | Q36331064 | ||
| Current trends in pancreatic cystic neoplasms | Q37249696 | ||
| Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period | Q37279916 | ||
| International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas | Q38017783 | ||
| Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis | Q38082269 | ||
| 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas | Q40149647 | ||
| High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound | Q43418185 | ||
| MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas | Q43619866 | ||
| Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain | Q46643162 | ||
| Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report | Q47259816 | ||
| Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study | Q47635370 | ||
| Small (Sendai negative) branch-duct IPMNs: not harmless. | Q50928326 | ||
| Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness. | Q53085886 | ||
| Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas. | Q53142243 | ||
| Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. | Q53471113 | ||
| The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. | Q53507908 | ||
| Prevalence of incidental pancreatic cysts in the adult population on MR imaging | Q57645260 | ||
| Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation | Q57845750 | ||
| P433 | issue | 13 | |
| P921 | main subject | pancreas | Q9618 |
| invasive carcinoma | Q19000601 | ||
| P304 | page(s) | 4348-4355 | |
| P577 | publication date | 2013-09-18 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram | |
| P478 | volume | 20 |
| Q36227985 | A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas |
| Q55292571 | Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines? |
| Q39025112 | Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium |
| Q64108315 | Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions: 2017 Consensus Recommendations of the Korean Society of Abdominal Radiology |
| Q42243988 | Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts |
| Q38224748 | IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection |
| Q34438494 | Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the International Consensus Guidelines for the Management of IPMN. |
| Q88028082 | Incidental Cystic Lesions in the Pancreas: Resect? EUS? Follow? |
| Q39364318 | Inference for the difference in the area under the ROC curve derived from nested binary regression models |
| Q34548931 | International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative |
| Q26796503 | Management of Incidental Pancreatic Cystic Lesions |
| Q38682495 | Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| Q38831886 | Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report |
| Q38521211 | Pancreatic Resection for Side-Branch Intraductal Papillary Mucinous Neoplasm (SB-IPMN): a Contemporary Single-Institution Experience |
| Q99555697 | Predictive Features of Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis |
| Q89302721 | Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas |
| Q35096156 | Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. |
| Q39157286 | The Clinical Indications for Limited Surgery of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| Q36275909 | Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease |
| Q91672108 | Validation and head-to-head comparison of four models for predicting malignancy of intraductal papillary mucinous neoplasm of the pancreas: A study based on endoscopic ultrasound findings |
| Q36751497 | What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses |
Search more.